Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02533713 · ClinicalTrials.gov registry record · NA
Effects of Exoskeleton-Assisted Gait Training on Bone Health and Quality of Life
A NA study, sponsored by Craig Hospital.
- Active
- Registry status
- NA
- Development phase
- 36
- Enrollment target
NCT02533713: Active NA study, sponsored by Craig Hospital.
NCT02533713 is a NA study that is active but no longer recruiting, run by Craig Hospital. The registered enrollment target is 36 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02533713, a NA study, is active but no longer recruiting, sponsored by Craig Hospital.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 36 participants
- Enrollment target
Study Summary
This is a randomized clinical trial to quantify the effects of exoskeleton-assisted gait on the musculoskeletal system and health-related quality of life.
Primary Outcome
Assessed by finite element analysis of quantitative CT scan (QCT) of the knee, values indicate measured epiphysis compressive strength index
Interventions
- DEVICE Exoskeleton assisted gait training
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36 participants |
| Start Date | 2017-07-01 |
| Est. Completion | 2022-12-01 |
| Phase | NA |
What the registry record for NCT02533713 still lists
NCT02533713 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 36 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 0 conditions, and to 1 intervention - of which Exoskeleton assisted gait training is the first listed.
NCT02533713 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02533713 about?
NCT02533713 is a clinical study titled "Effects of Exoskeleton-Assisted Gait Training on Bone Health and Quality of Life". This is a randomized clinical trial to quantify the effects of exoskeleton-assisted gait on the musculoskeletal system and health-related quality of life.
What is the current status of trial NCT02533713?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 36 participants. The study started on 2017-07-01. Estimated completion is 2022-12-01.
What interventions are being tested in trial NCT02533713?
The interventions under investigation include: Exoskeleton assisted gait training (DEVICE).
Who is sponsoring clinical trial NCT02533713?
This trial is sponsored by Craig Hospital, which has 29 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02533713's enrollment target sits among peer trials
36 1541st of 2000 higher than 437 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00929006 · 36 participants · Early Phase 1
Acute Progesterone Suppression of Wake vs. Sleep Luteinizing Hormone Pulse Frequency in Pubertal Girls With and Without Hyperandrogenism
- NCT01891318 · 36 participants · Phase 1
Neoadjuvant Radiosurgery for Resectable Brain Metastases: Phase I/II Study
- NCT02291848 · 36 participants · Phase 1
Tumor-Associated Antigen-Specific Cytotoxic T-Lymphocytes for Multiple Myeloma
- NCT02366819 · 36 participants · Phase 4
Genetic Analysis-Guided Irinotecan Hydrochloride Dosing of mFOLFIRINOX in Treating Patients With Locally Advanced Gastroesophageal or Stomach Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI